Medtronic presents positive data on TAVR, TMVR devices
Medtronic (NYSE:MDT) announced data from multiple trials supporting its transcatheter heart valve replacement devices.
Stay updated with breaking news from Pathological Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic (NYSE:MDT) announced data from multiple trials supporting its transcatheter heart valve replacement devices.
Medtronic, Edwards and Abbott presented positive data at TCT as TAVR, TEER and renal denervation innovations continue to arrive.
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets
When physician and pathologist Dorothy Andersen confronted a slew of confounding infant deaths, she suspected the accepted diagnosis wasn’t right. Her medical sleuthing led to the world’s understanding of cystic fibrosis, a disease that affects the lungs, the pancreas and a host of other organs. But she is by no means a household name. Who was this scientist, and how did she come to quietly make such an important medical contribution? This is the Lost Women of Science podcast